Abstract
Purpose Intrinsic and acquired resistance limit the therapeutic benefits of inhibitors of oncogenic BRAF in melanoma. To identify microRNAs (miRNAs) a......
小提示:本篇文献需要登录阅读全文,点击跳转登录